Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Mineralys Therapeutics (MLYS) · oqro.io/stocks/MLYS · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
A Mineralys Therapeutics director paid $15M out of pocket for Mineralys Therapeutics shares. 1 other person at Mineralys Therapeutics bought some too, in the same month. It was the first purchase in 6 months.
A Mineralys Therapeutics director paid $30M out of pocket for Mineralys Therapeutics shares. 1 other person at Mineralys Therapeutics bought some too, in the same month. It was the first purchase in 6 months.
A Mineralys Therapeutics director paid $3.5M out of pocket for Mineralys Therapeutics shares. 3 other people at Mineralys Therapeutics bought some too, in the same month.
A major shareholder of Mineralys Therapeutics paid $8.1M out of pocket for Mineralys Therapeutics shares. 3 other people at Mineralys Therapeutics bought some too, in the same month. Shares held went up 12% with this purchase.
A Mineralys Therapeutics director paid $8.1M out of pocket for Mineralys Therapeutics shares. 3 other people at Mineralys Therapeutics bought some too, in the same month. Shares held went up 12% with this purchase.
A Mineralys Therapeutics director paid $17.5M out of pocket for Mineralys Therapeutics shares. 3 other people at Mineralys Therapeutics bought some too, in the same month. Shares held went up 43% with this purchase.
0 open-market purchases and 2 open-market sales by insiders of MLYS between Feb 10, 2026 and today, placed against the company's last 4 earnings releases. The latest on file was filed Nov 4, 2026. The data provider lists the next release for Mar 10, 2027; that date may change.
PurchaseSale30 days before a release30 days after
Trades in the 30 days around each of the last earnings releases
Jon Congleton, Chief Executive Officer, Sep 30, 2026, about $1.91M. Sold 35 days before the company's next earnings release on 2026-11-04Form 4
Brian Taylor Slingsby, Director, Sep 22, 2026, about $3.01M. Sold 42 days after the company's previous earnings release on 2026-08-11Form 4
Companies set trading windows, which usually close shortly before results and reopen after them, and insiders may trade under 10b5-1 plans adopted months earlier. A date alone does not show what a person knew or why they traded. Past release dates are the dates the company filed its 8-K with Item 2.02. An upcoming date, when one is mentioned, comes from the data provider's earnings calendar (Finnhub): it is not a company filing, it is not estimated by OQRO, and it may change. Open-market purchases and sales as reported on Form 4. Largest purchases around earnings, all companies